Micro Cap Stocks
Micro-cap stocks refer to public companies with a market capitalization between $50 million and $300 million. Though small in size, micro-cap stocks can offer investors huge upside potential. However, these stocks also come with higher volatility and risk compared to large-cap stocks. Our micro-cap stock news section provides investors with the latest news, financial analysis, and stock updates on these overlooked hidden gems.
With over 3,000 micro-cap stocks trading on the major exchanges, it can be challenging for investors to analyze each potential opportunity in depth. That’s where our team of experienced analysts come in. We dig deep into micro-cap company financials, market opportunities, and management teams to uncover the most promising micro-cap stocks with the biggest return potential.
While many investors focus on large-cap stocks in the S&P 500, small-cap stocks often fly under the radar. This leads to potential bargains and discounted prices for savvy investors willing to take on some added risk. The key is separating the long-term winners from the duds. Our stock analysis and news on these smaller companies will help do the hard work for you.
We cover breaking news and developments that move stock prices, providing investors with insightful analysis instead of just reporting the news. From clinical trial results in biotech penny stocks to FDA approvals, new product launches, acquisitions and strategic partnerships, our experts connect the dots on how different events impact micro-cap companies.
If you’re looking to spice up your portfolio with some calculated investing on small-cap stocks with high growth potential, you’ve come to the right place. Our coverage provides a transparent view of both risks and opportunities, so you can invest in micro-cap stocks with confidence.
US Stocks Surge as Inflation Hits 3.4% in December
U.S. stocks displayed a bullish trend this morning, witnessing a notable upswing. The Nasdaq Composite soared, gaining over 50 points on Thursday, highlighting a ...
5 Overbought Materials Stocks
Five Stocks You May Want to Reconsider
As of Jan. 11, 2024, selected stocks in the materials sector might be waving a caution signal to investors who prioritize momentum in their ...
Winning Stocks: A Glimpse at Transphorm, Canaan, and Others Soaring High Before Market Open
Pre-market futures point to a strong opening for U.S. stocks today, with the Nasdaq futures up around 50 points on Thursday. The spotlight shines ...
Stock Market Update: Nasdaq Up 50 Points; Crude Oil Inventories Rise
Stock Market Update: Nasdaq Up 50 Points; Crude Oil Inventories Rise
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 50 points on Wednesday. The Dow traded up 0.17% to 37,588.15 ...
WD-40 Delights Investors With Outstanding First-Quarter Earnings Report
Shares of the venerable WD-40 Company WDFC surged in Wednesday’s trading session, triggering a wave of applause from investors when the company announced an ...
Impressive Stock Movement: Amarin Soars as Crude Oil Falls
Impressive Stock Movement: Amarin Soars as Crude Oil Falls
U.S. stocks demonstrated buoyancy in the later hours of trading, with the Dow Jones index making substantial gains, climbing over 100 points on Wednesday. ...
Global Trends in the Marijuana Industry
Rising Legal Cannabis Sales in British Columbia British Columbia, Canada, has witnessed a staggering 40.9% surge in legal cannabis sales, marking a total of ...
William Blair Notes Aclaris Therapeutics’ Encouraging Trial Results But Flags Concerns
Analyst Highlights Aclaris Therapeutics’ Encouraging Trial Results But Flags Concerns
Wednesday, William Blair acknowledged ATI-1777 data towards a positive trend in efficacy and safety, comparing it favorably to other competitive therapies like Roivant Sciences ...
Cell-Programming Powerhouse Ginkgo Bioworks’ Thrives Amid Revenue Surge, Program Adjustments
Cell-Programming Powerhouse Ginkgo Bioworks’ Thrives Amid Revenue Surge, Program Adjustments
Wednesday, Ginkgo Bioworks Holdings Inc DNA released preliminary FY23 sales of $250 million-$260 million, compared to the consensus of $258.65 million. Preliminary cell engineering and biosecurity ...
Yixin Group Ltd.
Yixin Sails Away from Youthful Joint Venture to Navigate Clear Waters of China Auto Market
Key Points: Yixin to sell 49% stake in two-year-old joint venture to Qingdao Caitong Yixin’s auto financing business thrives amidst fluctuating Chinese car market, ...